File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Oral mucosal fungal infections

TitleOral mucosal fungal infections
Authors
Issue Date2009
PublisherBlackwell Munksgaard. The Journal's web site is located at http://www.blackwellpublishing.com/journals/PRD
Citation
Periodontology 2000, 2009, v. 49 n. 1, p. 39-59 How to Cite?
Abstract
This review has provided an overview of variants of oral mucosal candidiasis and current therapeutic techniques followed by an outline of the rare oral mycoses and their management. The advent of the HIV infection and the increasing prevalence of compromised individuals in the community as a consequence of surgical and medical advances have resulted in a resurgence of opportunistic infections, including oral candidiasis and other rare mycoses that were once considered exotic. It is now recognized that oral candidiasis may present in many clinical guises, including the classic white lesion of thrush as well in as nondescript, red mucosal lesions that may confound the unwary clinician. Other mycotic diseases, such as aspergillosis, cryptococcosis, histoplasmosis and mucormycosis, may manifest intra-orally, both as primary lesions and as secondary manifestations of systemic disease. Periodontal manifestations of mycotic diseases are rare. If at all, such lesions may present as erythematous areas as in linear gingival erythema and rarely as ulcerations in exotic mycoses. Most of the oral mycoses respond well to either topical or systemic therapy with the polyenes or azoles. In general, the management of oral fungal infections has been revolutionized by the triazole group of drugs, fluconazole and itraconazole, although recent reports indicate an alarming increase of resistant organisms, in particular to fluconazole. © 2009 Blackwell Munksgaard.
Persistent Identifierhttp://hdl.handle.net/10722/58107
ISSN
2013 Impact Factor: 3.000
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorSamaranayake, LPen_HK
dc.contributor.authorKeung Leung, Wen_HK
dc.contributor.authorJin, Len_HK
dc.date.accessioned2010-05-31T03:23:55Z-
dc.date.available2010-05-31T03:23:55Z-
dc.date.issued2009en_HK
dc.identifier.citationPeriodontology 2000, 2009, v. 49 n. 1, p. 39-59en_HK
dc.identifier.issn0906-6713en_HK
dc.identifier.urihttp://hdl.handle.net/10722/58107-
dc.description.abstractThis review has provided an overview of variants of oral mucosal candidiasis and current therapeutic techniques followed by an outline of the rare oral mycoses and their management. The advent of the HIV infection and the increasing prevalence of compromised individuals in the community as a consequence of surgical and medical advances have resulted in a resurgence of opportunistic infections, including oral candidiasis and other rare mycoses that were once considered exotic. It is now recognized that oral candidiasis may present in many clinical guises, including the classic white lesion of thrush as well in as nondescript, red mucosal lesions that may confound the unwary clinician. Other mycotic diseases, such as aspergillosis, cryptococcosis, histoplasmosis and mucormycosis, may manifest intra-orally, both as primary lesions and as secondary manifestations of systemic disease. Periodontal manifestations of mycotic diseases are rare. If at all, such lesions may present as erythematous areas as in linear gingival erythema and rarely as ulcerations in exotic mycoses. Most of the oral mycoses respond well to either topical or systemic therapy with the polyenes or azoles. In general, the management of oral fungal infections has been revolutionized by the triazole group of drugs, fluconazole and itraconazole, although recent reports indicate an alarming increase of resistant organisms, in particular to fluconazole. © 2009 Blackwell Munksgaard.en_HK
dc.languageengen_HK
dc.publisherBlackwell Munksgaard. The Journal's web site is located at http://www.blackwellpublishing.com/journals/PRDen_HK
dc.relation.ispartofPeriodontology 2000en_HK
dc.subject.meshAntifungal Agents - therapeutic useen_HK
dc.subject.meshCandidiasis, Oral - complications - drug therapy - microbiology - pathologyen_HK
dc.subject.meshDenture, Complete, Upper - adverse effectsen_HK
dc.subject.meshHIV Infections - complicationsen_HK
dc.subject.meshHumansen_HK
dc.subject.meshMouth Mucosa - microbiologyen_HK
dc.subject.meshMycoses - drug therapy - microbiology - pathologyen_HK
dc.titleOral mucosal fungal infectionsen_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0906-6713&volume=49&spage=39&epage=59&date=2009&atitle=Oral+mucosal+fungal+infectionsen_HK
dc.identifier.emailSamaranayake, LP:lakshman@hku.hken_HK
dc.identifier.emailKeung Leung, W:ewkleung@hkucc.hku.hken_HK
dc.identifier.emailJin, L:ljjin@hkucc.hku.hken_HK
dc.identifier.authoritySamaranayake, LP=rp00023en_HK
dc.identifier.authorityKeung Leung, W=rp00019en_HK
dc.identifier.authorityJin, L=rp00028en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1111/j.1600-0757.2008.00291.xen_HK
dc.identifier.pmid19152525en_HK
dc.identifier.scopuseid_2-s2.0-57849103561en_HK
dc.identifier.hkuros154199en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-57849103561&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume49en_HK
dc.identifier.issue1en_HK
dc.identifier.spage39en_HK
dc.identifier.epage59en_HK
dc.identifier.eissn1600-0757-
dc.identifier.isiWOS:000261838700003-
dc.publisher.placeDenmarken_HK
dc.identifier.scopusauthoridSamaranayake, LP=7102761002en_HK
dc.identifier.scopusauthoridKeung Leung, W=25224691800en_HK
dc.identifier.scopusauthoridJin, L=7403328850en_HK
dc.identifier.citeulike3821160-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats